Tiotropium Bromide

The FDA has approved Lupin’s 18 µg capsules of tiotropium bromide inhalation powder, according to a manufacturer-issued press release.

Daily tiotropium via the HandiHaler device improved lung function but did not reduce frequency of exacerbations over 6 months in patients with stable bronchiectasis, according to results published in European Respiratory Journal.

Adding ensifentrine to tiotropium demonstrated clinically important improvements in lung function and quality of life at 4 weeks in patients with moderate to severe COPD, according to a new study.

NEW ORLEANS — In a post hoc analysis of pooled data from four phase 3 studies, combination therapy with tiotropium plus olodaterol resulted in greater improvements in lung function and symptoms than with tiotropium alone in patients with COPD who were not using inhaled corticosteroids.

Among patients with COPD, targeted lung denervation in addition to optimal pharmacotherapy, as compared with pharmacotherapy alone, was associated with fewer respiratory events including exacerbations, according to data from the AIRFLOW-2 study.